Camrelizumab Combined With Apatinib Mesylate Tablets and Nab-paclitaxel in the Second-line Treatment of Advanced Gastric Cancer

Condition:   Locally Advanced or Metastatic Gastric Adenocarcinoma Interventions:   Drug: Camrelizumab;   Drug: Apatinib Mesylate;   Drug: nab-paclitaxel Sponsor:   The First Affiliated Hospital of Xiamen University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials